(ANG) II via ANG II type 1 receptors (AT1R) activates renal sodium transporters including Na-K-ATPase and regulates sodium homeostasis and blood pressure. It is reported that at a high concentration, ANG II either inhibits or fails to stimulate Na-K-ATPase. However, the mechanisms for these phenomena are not clear. Here, we identified the signaling molecules involved in regulation of renal proximal tubular Na-KATPase at high ANG II concentrations. Proximal tubules from spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats were incubated with low concentrations of ANG II (pM), which activated Na-K-ATPase in both the groups; however, the stimulation was more robust in SHR. A high concentration of ANG II (M) failed to stimulate Na-K-ATPase in WKY rats. However, in SHR ANG II (M) continued to stimulate Na-K-ATPase, which was sensitive to the AT1R antagonist candesartan. In the presence of N G -nitro-Larginine methyl ester (L-NAME), a nitric oxide (NO) synthase (NOS) inhibitor, ANG II (M) caused stimulation of Na-K-ATPase in proximal tubules of WKY rats while having no further stimulatory effect in SHR. ANG II (M), via AT1R, increased proximal tubular NO levels in WKY rats but not in SHR. In SHR, NOS was uncoupled as incubation of proximal tubules with ANG II and L-arginine, a NOS substrate, caused superoxide generation only in SHR and not in WKY rats. The superoxide production in SHR was sensitive to L-NAME. There was exaggerated proximal tubular AT1R-G protein coupling and NAD(P)H oxidase activation in response to ANG II (M) in proximal tubules of SHR compared with WKY rats. In SHR, inhibition of NADPH oxidase restored NOS coupling and ANG II-induced NO accumulation. In conclusion, at a high concentration ANG II (M) activates renal NO signaling, which prevents stimulation of Na-K-ATPase in WKY rats. However, in SHR ANG II (M) overstimulates NADPH oxidase, which impairs the NO system and leads to continued Na-K-ATPase activation.
porters can contribute to hypertension (1, 2) . It is recognized that ANG II via AT1R can modulate sodium reabsorption in a manner such that low concentrations (pM) of ANG II promote sodium reabsorption by stimulating Na-K-ATPase, whereas at high concentrations (M) of ANG II this stimulatory effect on Na-K-ATPase is lost (9) . At circulating concentrations, ANG II maintains a positive sodium balance by directly stimulating sodium transporters or indirectly via aldosterone release. However, the renal proximal tubular concentration of ANG II is reported to be high during pathological situations, and thus regulation of renal Na-K-ATPase at a high concentration of ANG II is relevant in conditions such as hypertension (16) .
The mechanism by which a high concentration of ANG II (M) exerts its effect on Na-K-ATPase is not completely understood. It is reported that high concentrations of ANG II via AT1R can activate nitric oxide (NO)-cGMP signaling in rat proximal tubules (12, 24) . Studies show that defective NO signaling can influence ANG II-mediated Na-K-ATPase regulation (1) . Interestingly, ANG II is known to activate NADPH oxidase and cause superoxide production. Superoxides can reduce NO bioavailability by either formation of peroxynitrite or by uncoupling NO synthase (NOS). We have reported that defective NO signaling can affect Na-K-ATPase regulation at high concentrations of ANG II and thus can contribute to hypertension in Sprague-Dawley rats treated with prooxidant L-buthionine sulfoximine (1) . Therefore, the present study was designed to determine the involvement of the NO system in AT1R-mediated Na-K-ATPase regulation at high concentrations of ANG II in spontaneously hypertensive rats (SHR), a genetic model of essential hypertension, and their normotensive control Wistar-Kyoto (WKY) rats.
METHODS

Animals.
Male 12-to 14-wk-old SHR and WKY rats were purchased from Charles River Laboratories (Wilmington, MA). The rats were placed in plastic cages with free access to tap water and standard rat chow (Purina Mills, St. Louis, MO). All experiments were performed according to University of Houston guidelines, and protocols were approved by the Institutional Animal Care and Use Committee.
Animal surgery. Implantable radio transmitters (TA11PA-C40; Data Sciences, St. Paul, MN) were used to measure conscious blood pressure in individual animals. Anesthesia was induced by 5% isoflurane and maintained by 2.5-3% of isoflurane with a face mask throughout the surgery. After a midline abdominal incision was made, the abdominal aorta was exposed by using sterile cotton swabs. The catheter of the telemetric device was inserted into the abdominal aorta and guided upstream. To secure the catheter to the aorta, tissue adhesive (Vetbond, 3M Animal Care Products, St Paul, MN) was used. The body of the telemetric device was placed in the abdominal cavity and sutured to the abdominal musculature. The abdominal musculature and skin were closed individually. The surgery was performed under sterile conditions on a heating pad (37°C). Analgesia was achieved by the administration of buprenorphine (0.05 mg/kg sq) every 12 h for 2 days. Animals were allowed 1 wk for recovery before blood pressure measurements were recorded.
Preparation of renal proximal tubules. Proximal tubules were prepared as described previously (6) . Briefly, rats were anesthetized with pentobarbital sodium (50 mg/kg ip), and, after a midline incision, the aorta was cannulated below the kidneys. In situ digestion was accomplished by perfusing an enzyme solution of 230 U/ml collagenase and 250 U/ml hyaluronidase (Sigma, St. Louis, MO). Enrichment of proximal tubules was carried out using a 25% Ficoll density gradient in Krebs-Henseleit buffer B (KHB-B) without calcium [KHB-B (in mM): 118 NaCl, 27.2 NaHCO 3, 4 KCl, 0.12 MgCl2, 1 KH2PO4, 5 glucose, and 10 HEPES, pH 7.4] . The band at the Ficoll-KHB-B buffer interface was collected and washed with KHB (5) by centrifugation at 250 g for 5 min. Proximal tubular viability was checked by using a trypan blue exclusion test. Protein was determined by using a bicinchoninic acid kit (Pierce Chemicals).
Na-K-ATPase activity. Na-K-ATPase activity was determined as described by Quigley and Gotterer (18) . Briefly, renal proximal tubules (1 mg protein) were incubated without (basal) and with ANG II (10 Ϫ10 or 10 Ϫ6 M) at 37°C for 15 min in a water bath. After incubation, the proximal tubules were lysed by snap freezing in liquid nitrogen. The lysed tubules were used to assay ouabain (4 mM)-sensitive Na-K-ATPase activity, which was determined by phosphate hydrolysis of ATP (4 mM). The inorganic phosphate released was determined colorimetrically as described by Taussky and Shorr (21) .
[ 35 S]GTP␥S binding assay. The assay was performed as described earlier (11) . Briefly, the reaction mixture containing 100 l of 0.6 nM [ 35 S]GTP␥S, ANG II (10 Ϫ6 M), and 5 g of proximal tubular membrane protein was incubated at 30°C for 60 min. Nonspecific [ 35 S]GTP␥S binding was determined in the presence of 100 M unlabeled GTP␥S. The reaction was stopped by rapid filtration on GF/C filters under vacuum, and radioactivity was determined by a liquid scintillation counter (Beckman Coulter, Brea CA).
Immunoblotting. Proximal tubular homogenate was used to immunoblot AT1R and glyceraldehyde 3-phosphate dehydrogenase. Proteins were solubilized in Laemmli buffer (13), resolved by SDS-PAGE and transferred to nitrocellulose membranes. The membranes were blocked with 5% bovine serum albumin (Pierce Chemicals) and incubated with antibodies directed against AT1R (Santa Cruz Biotechnology, Santa Cruz, CA) and glyceraldehyde 3-phosphate dehydrogenase (Calbiochem, La Jolla, CA) in 0.1% Tris-buffered saline followed by incubation with horseradish peroxidase-conjugated secondary antibodies. The signal was detected with enhanced chemiluminescence substrate (Santa Cruz Biotechnology) and quantified by Kodak Imagining System (Rochester, NY).
Determination of NO level. Renal proximal tubules were incubated without (basal) or with ANG II (10 Ϫ6 M) in the presence or absence of AT1R blocker candesartan (1 M), and tissues were snap frozen in liquid nitrogen followed by homogenization. The levels of NO were determined colorimetrically using a nitrate/nitrite assay kit (Cayman Chemical, Ann Arbor, MI) according to the manufacturer's protocol.
Superoxide detection. Fluorescence spectrometric assay of superoxide production was performed as detailed by Satoh et al. (20) . Briefly, proximal tubules were incubated with and without ANG II (10 Ϫ6 M) for 15 min. Oxidation of dihydroethidium to ethidium in the presence of NADH or L-arginine was used as a measure of superoxide production. Conversion of dihydroethidium to ethidium in the absence of ANG II was considered as basal superoxide production.
Statistics analysis. Differences between the means were evaluated using an unpaired Student's t-test or one-way ANOVA with a Newman-Keuls multiple test, as appropriate. P Ͻ 0.05 was considered statistically significant.
RESULTS
Both, SHR and WKY rats had similar food (WKY 19.4 Ϯ 2.0, SHR 18.6 Ϯ 1.0, g/day) and water (WKY 40.0 Ϯ 3.5, SHR 38.5 Ϯ 2.6 ml/day) intake and body weights (WKY 309.3 Ϯ 5.0, SHR 297.5 Ϯ 4.0 g). Compared with WKY rats, SHR had significantly higher mean arterial pressure (WKY 98.7 Ϯ 1.3, SHR 134.7 Ϯ 1.5 mmHg).
Effect of ANG II on proximal tubular Na-K-ATPase activity. Incubation of proximal tubules with a low concentration of ANG II (10 Ϫ10 M) caused stimulation of Na-K-ATPase in both SHR and WKY rats (Fig. 1A) . However, ANG II-induced stimulation of Na-K-ATPase was significantly higher in SHR compared with WKY rats (Fig. 1A) . A higher concentration of ANG II (10 Ϫ6 M) failed to activate Na-K-ATPase in WKY rats; yet, at this concentration, ANG II continued to stimulate Na-K-ATPase in SHR (Fig. 1A) . The basal Na-K-ATPase activity was similar in SHR and WKY rats (Fig. 1B) . As shown in Fig. 1C , stimulation of Na-K-ATPase by ANG II (10 Ϫ6 M) in SHR was sensitive to the AT1R antagonist candesartan (1 M).
Role of NO in ANG II-mediated Na-K-ATPase regulation. To investigate whether NO has a role in ANG II (10 Ϫ6 M)-mediated Na-K-ATPase regulation, we pretreated proximal tubules of SHR and WKY rats with NOS inhibitor N G -nitro-L-arginine methyl ester (L-NAME). In WKY rats, L-NAME (1 mM) treatment resulted in significant stimulation of Na-KATPase by ANG II (Fig. 2A) . However, L-NAME treatment did not change ANG II-induced Na-K-ATPase stimulation in SHR ( Fig. 2A) .
Incubation of proximal tubules with ANG II (10 Ϫ6 M) caused a significant increase in NO production in WKY rats, but ANG II did not significantly increase NO production in SHR (Fig. 2B) . ANG II-induced NO production in WKY rats was sensitive to the AT1R antagonist candesartan (1 M) (Fig.  2B) . The basal levels of NO were similar in both SHR and WKY rats (Fig. 2B) .
NOS uncoupling. In the presence of the NOS substrate L-arginine (1 mM), ANG II (10 Ϫ6 M) caused superoxide production in proximal tubules of SHR but not in WKY rats (Fig. 3A) . Superoxide production in proximal tubules of SHR was sensitive to the NOS inhibitor L-NAME (1 mM) (Fig. 3A) . There was no effect of L-NAME treatment on NOS-mediated superoxide production in proximal tubules of WKY rats (Fig. 3A) .
Effect of ANG II on NADPH oxidase activation. Incubation of proximal tubules with ANG II (10 Ϫ6 M) and the NADPH oxidase substrate NADH (0.1 mM) resulted in superoxide production in both SHR and WKY rats (Fig. 3B) . However, the generation of superoxides in response to ANG II was significantly higher in SHR compared with WKY rats (Fig. 3B) . ANG II-induced superoxide production was sensitive to the NADPH oxidase inhibitor diphenyleneiodonium (DPI; 0.1 mM) in both SHR and WKY rats (Fig. 3B) .
Involvement of NADPH oxidase in NOS uncoupling. To further verify whether ANG II-induced superoxide production plays any role in reducing NO generation in SHR, we determined the effect of the NADPH oxidase inhibitor DPI on ANG II-mediated NO production in proximal tubules of SHR and WKY rats. In the presence of DPI (0.1 mM), there was an increase in ANG II-induced NO production in SHR (Fig. 3C) . However, DPI treatment did not cause any changes in ANG II-mediated NO production in WKY rats (Fig. 3C) . Furthermore, DPI treatment blocked NOS-mediated superoxide production in response to ANG II in proximal tubules from SHR (Fig. 3D) . DPI treatment had no effect on NOS-mediated superoxide production in WKY rats (Fig. 3D) .
Renal proximal tubular AT1R protein expression and G protein coupling. Western blot analysis showed similar AT1R protein expression in proximal tubules of SHR and WKY rats (Fig. 4A) (Fig. 4C) .
DISCUSSION
The results of our study show that in WKY rats ANG II regulates proximal tubular Na-K-ATPase in a biphasic manner in that at a low concentration (pM) it activates Na-K-ATPase while at a high concentration (M) there is loss of stimulation. In these rats, ANG II (M) increased proximal tubular NO levels and L-NAME restored the stimulation of Na-K-ATPase at a higher ANG II concentration, indicating the role of NO in loss of stimulation. On the other hand, in SHR ANG II caused exaggerated stimulation of Na-K-ATPase at a lower concentration and continued the stimulation at a higher concentration as well. In these rats, NOS was uncoupled as ANG II (M) failed to increase tubular NO levels and coincubation of tu- bules with ANG II (M) and L-arginine caused superoxide generation. Also, in these animals there was higher proximal tubular AT1R-G protein coupling and NAD(P)H oxidase activation in response to ANG II (M). NAD(P)H inhibition restored NOS coupling as incubation of proximal tubules with ANG II (M) restored NO generation, which also abolished ANG II (M)-induced Na-K-ATPase activation in SHR. Taken together, our data suggest that in WKY rats the loss of ANG II (M)-induced Na-K-ATPase stimulation is mediated via a NO pathway. However, in SHR higher NAD(P)H oxidase activation caused NOS uncoupling and impaired the NO system, which leads to continued ANG II (M)-induced stimulation.
Renal proximal tubular Na-K-ATPase, expressed on basolateral membranes, plays an important role in sodium transport, and studies show that perturbation in Na-K-ATPase activity can lead to sodium imbalance and thereby contribute to hypertension. The regulation of Na-K-ATPase in response to ANG II is such that picomolar-nanomolar concentrations of ANG II stimulate Na-K-ATPase, whereas at micromolar concentrations ANG II either inhibits or fails to stimulate Na-K-ATPase (3, 9) . In agreement with these studies, we observed a loss of Na-K-ATPase stimulation at high concentrations of ANG II in WKY rats. It is worth noting that at low concentrations of ANG II we observed stimulation of Na-K-ATPase in both SHR and WKY rats, suggesting that AT1R are functional in proximal tubular preparations. Interestingly, in SHR we observed stimulation of Na-K-ATPase at high concentrations of ANG II, and this stimulation was sensitive to an AT1R antagonist, suggesting the involvement of AT1R. Navar et al. (16, 17) have reported that the proximal tubular concentration of ANG II is much higher than the plasma concentration because there are two sources of ANG II in proximal tubules, local synthesis and glomerular filtration, and there is a further increase in intrarenal ANG II levels during pathological conditions such as hypertension. Thus increase in intrarenal ANG II levels may contribute to sodium retention and hypertension if sodium transporter stimulation is maintained at high concentrations. Therefore, it is possible that stimulation of Na-K-ATPase at high concentrations of ANG II may cause an increase in sodium reabsorption and contribute to hypertension in SHR.
Stimulation of Na-K-ATPase in response to low concentrations of ANG II is shown to be mediated by various protein kinases, including MAP kinase and protein kinase C (1-3) .
However, the mechanism that causes inhibition or loss of stimulation of Na-K-ATPase at high concentrations of ANG II is not clearly understood. Studies from our laboratory and others have shown that ANG II abolishes the stimulation of Na-K-ATPase via NO-cGMP signaling in rat renal proximal tubules (1, 15) . Here, we also studied the role of NO signaling in ANG II-mediated Na-K-ATPase regulation by treating the proximal tubules with the NOS inhibitor L-NAME in SHR and WKY rats. Our results show that L-NAME treatment resulted in ANG II-induced stimulation of Na-K-ATPase in proximal tubules of WKY rats. We did not observe any effect of L-NAME treatment on ANG II-induced Na-K-ATPase stimulation in SHR. Interestingly, after L-NAME treatment ANG II produced similar stimulation of Na-K-ATPase in proximal tubules of SHR and WKY rats. These results suggest that ANG II via NO signaling could cause a loss of Na-K-ATPase stimulation in WKY rats, and this pathway might be defective in SHR. However, reports from other laboratories have shown that ANG II-mediated inhibition of sodium transporters involves 6-epoxy-eicosatrienoic acid, PKC, or decreased Na-KATPase turnover. Also, it has been shown that increased production of peroxynitrite could be involved in ANG IImediated Na-K-ATPase inhibition. Although we did not study these pathways, it is possible that differences in cell/species type or experimental design could modulate ANG II-mediated Na-K-ATPase regulation. The present study was performed in isolated proximal tubules from SHR, while others have used rabbit proximal tubular cultures or ventricular myocytes (8, 14, 19, 23) . To further investigate the effect of ANG II on NO production, we determined NO levels in ANG II (10 Ϫ6 M)-treated proximal tubules of SHR and WKY rats. Our results show that ANG II treatment increased NO production in WKY rats, and this increase was sensitive to an AT1R antagonist. However, ANG II failed to increase NO levels in proximal tubules of SHR. These results suggest that NO production in response to ANG II is defective in SHR and could be responsible for continued ANG II-induced Na-K-ATPase stimulation.
One of the mechanisms that could reduce NO production is NOS uncoupling. It is known that uncoupled NOS produces superoxides instead of NO. To investigate whether NOS is uncoupled in proximal tubules of SHR, we determined ANG II-induced NOS dependent superoxide production in SHR and WKY rats. Our results showed that ANG II produced L-arginine-dependent superoxides in SHR, which were sensitive to the NOS inhibitor L-NAME, suggesting NOS uncoupling in SHR. ANG II failed to produce L-arginine-mediated superoxides in proximal tubules of WKY rats. A previous study from our laboratory showed that ANG II via NADPH oxidase activation leads to superoxide production, which in turn causes NOS uncoupling (1). We found that treatment of proximal tubules with ANG II caused NADPH oxidase activation in both SHR and WKY rats. However, ANG II-induced NADPH oxidase activation was significantly higher in SHR compared with WKY rats. Interestingly, pretreatment of proximal tubules with the NADPH oxidase inhibitor DPI prevented ANG IIinduced, NOS-dependent superoxide production in SHR. Furthermore, DPI treatment in SHR also normalized NO production in response to ANG II. These data suggest that inhibition of NADPH oxidase decreases superoxide production and restores NOS coupling in SHR. We speculate that in SHR an increased ANG II-induced NADPH oxide activation could be contributing to NOS uncoupling. The uncoupled NOS not only fails to produce NO but could also increase superoxide production, which could further decrease NO bio availability. Therefore, we believe that inhibition of NADH oxidase could reduce superoxide levels and prevent NOS uncoupling.
To investigate the mechanism for higher stimulation of Na-K-ATPase at low concentrations of ANG II and increased ANG II-induced NADPH oxidase activation in proximal tubules of SHR, we determined AT1R protein expression and ANG II-induced G protein coupling. We found similar AT1R protein levels in proximal tubules of SHR and WKY rats. Interestingly, our data show that there was an increase in ANG II-induced AT1R-G protein coupling in SHR compared with WKY rats, which may have contributed to enhanced Na-KATPase and NAPDH activation in SHR.
In conclusion, our results show that micromolar concentrations of ANG II failed to activate Na-K-ATPase in WKY rats, yet in SHR it produced stimulation of Na-K-ATPase. Compared with WKY rats, we observed higher ANG II-induced NADPH oxidase activation, which may have led to NOS uncoupling and a decrease in ANG II-induced NO production in SHR. Defective ANG II-induced NO signaling could result in stimulation of Na-K-ATPase even at higher ANG II concentrations, which could lead to increased sodium reabsorption and subsequently contribute to development of hypertension.
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